AIM ImmunoTech, Inc. (AIM)

0.6944 +0.05 (+8.33%) USD  |  NYAM  |  Mar 06, 16:00
0.7349 +0.04 (+5.83%) After-Hours: 20:00
More

AIM ImmunoTech Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Agenus, Inc. --
Curis, Inc. --
Plus Therapeutics, Inc. --
Windtree Therapeutics, Inc. --